GFO Issue 98, Article Number: 2
Sub-title :
ABSTRACT
ABSTRACT
A detailed listing and analysis is provided of which Round 8 proposals have been approved.
Based on advice from the TRP, the Board divided eligible Round 8 proposals into five Categories, as follows:
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2: Proposals that are approved in principle, subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
- Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
- Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in Round 9 following major revision.
- Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
The Board approved "in principle" (to use its precise words) all proposals in Categories 1, 2 and 2B. However, some of the approvals are immediate and some are delayed, depending on future availability of funds. The prioritization is handled as follows:
- Category 1 proposals are approved immediately.
- Each country submitting a Category 2 or 2B proposal is assigned a disease burden index of 4 or 1 according to whether the disease burden is "very high" or not "very high". And each such country is assigned a poverty index of 4, 2 or 0 according to whether the country is low income, lower-middle income, or upper-middle income. The sum of these two indexes creates the Composite Index, whose value is therefore between 8 and 1. The higher the country's Composite Index, the sooner its Category 2 or 2B proposal will be approved.
- Category 2 proposals with a Composite Index of 8, 6 or 5 are immediately approved.
- Remaining Category 2 and 2B proposals will be approved in the following order, as pledges by donors to the Fund become available in the course of 2008-9:
1. Category 2, Composite Index 3
2. Category 2B, Composite Index 8
3. Category 2B, Composite Index 6
4. Category 2B, Composite Index 5
5. Category 2B, Composite Index 3
The number of Round 8 grants per Category and Composite Index are as follows:
Table 4: Round 8 results by Category and Composite Index
Category and Composite Index
Number of proposals
Amount requested
(Years 1-2)
Immediate approval: Category 1
16
USD 0.45 b.
Immediate approval: Category 2, Composite Index 8, 6 or 5
43
USD 1.68 b.
Delayed approval: Category 2, Composite Index 3
8
USD 0.18 b.
Delayed approval: Category 2B, Composite Index 8
6
USD 0.44 b.
Delayed approval: Category 2B, Composite Index 6
6
USD 0.10 b.
Delayed approval: Category 2B, Composite Index 5
8
USD 0.13 b.
Delayed approval: Category 2B, Composite Index 3
7
USD 0.09 b.
Subtotal: All Approved Proposals:
94
USD 3.06 b.
Not Approved: Category 3
63
USD 1.75 b.
Not Approved: Category 4
17
USD 0.43 b.
Not Approved: Removed sub-components of approved proposals
n/a
USD 0.56 b.
Subtotal: All Non-Approved Proposals:
80
USD 2.73 b.
Total: All Proposals
174
USD 5.79 b.
Round 8 results by applicant were as in Tables 5 and 6, below.
Table 5: Round 8 Results, by Country
Country
Disease component
Applicant
Decision
Category
(defined above)
Composite Index
(defined above)
Amount requested
(Years 1-2)
Amount requested
(Years 1-5)
Afghanistan
Malaria (disease part + HSS part)
CCM
Delayed approval
2B
5
EUR 30,075,545
EUR 55,397,259
Afghanistan
TB
CCM
Immediate approval
1
n/a
EUR 7,394,272
EUR 22,669,094
Algeria
HIV
CCM
Not approved
4
n/a
USD 15,252,168
USD 32,720,961
Angola
HIV
CCM
Not approved
4
n/a
USD 75,142,046
USD 235,955,998
Angola
TB
CCM
Not approved
4
n/a
USD 11,756,766
USD 25,098,444
Armenia
HIV (HSS part)
CCM
Immediate approval
2
6
EUR 1,466,930
EUR 2,062,995
Armenia
HIV (disease part)
CCM
Not approved
n/a
n/a
EUR 2,394,212
EUR 6,257,962
Armenia
TB
CCM
Immediate approval
1
n/a
EUR 2,006,371
EUR 6,205,708
Bangladesh
HIV
CCM
Not approved
3
n/a
USD 14,964,866
USD 48,892,309
Bangladesh
Malaria
CCM
Not approved
3
n/a
USD 22,729,707
USD 68,436,372
Bangladesh
TB (disease part + HSS part)
CCM
Immediate approval
2
8
USD 5,627,763
USD 77,430,875
Belarus
HIV (disease part + HSS part)
CCM
Immediate approval
1
n/a
EUR 11,120,812
EUR 25,389,385
Belarus
TB
CCM
Not approved
3
n/a
EUR 14,254,281
EUR 31,226,265
Benin
Malaria
CCM
Not approved
3
n/a
EUR 26,909,499
EUR 26,909,499
Benin
TB
CCM
Not approved
3
n/a
EUR 3,556,947
EUR 6,658,804
Bolivia
HIV
CCM
Not approved
3
n/a
USD 7,763,930
USD 23,802,395
Bolivia
Malaria
CCM
Delayed approval
2B
3
USD 6,744,407
USD 15,578,630
Bolivia
TB
CCM
Not approved
4
n/a
USD 9,191,385
USD 16,777,841
Bosnia & Herzegovina
HIV
CCM
Not approved
3
n/a
EUR 12,336,077
EUR 29,441,571
Bosnia & Herzegovina
TB
CCM
Not approved
3
n/a
EUR 5,722,028
EUR 9,796,973
Brazil
HIV
CCM
Not approved
3
n/a
EUR 9,372,000
EUR 30,000,000
Brazil
Malaria
CCM
Delayed approval
2
3
EUR 20,659,117
EUR 42,023,909
Brazil
TB
CCM
Not approved
3
n/a
EUR 40,191,174
EUR 80,560,970
Bulgaria
TB
CCM
Delayed approval
2B
3
EUR 3,661,435
EUR 10,527,766
Burkina Faso
HIV
CCM
Not approved
3
n/a
EUR 24,844,539
EUR 48,473,676
Burkina Faso
Malaria
CCM
Immediate approval
2
8
EUR 53,120,303
EUR 63,203,438
Burkina Faso
TB (disease part + HSS part)
CCM
Delayed approval
2B
8
EUR 12,045,997
EUR 27,167,685
Burundi
HIV
CCM
Delayed approval
2B
8
USD 41,315,145
USD 159,105,087
Cambodia
HIV
CCM
Not approved
3
n/a
USD 38,283,888
USD 134,514,948
Cambodia
TB (disease part + HSS part)
CCM
Not approved
3
n/a
USD 11,449,113
USD 34,686,505
Cameroon
HIV
CCM
Not approved
3
n/a
EUR 28,961,003
EUR 66,797,527
Cameroon
TB
CCM
Not approved
3
n/a
EUR 7,015,400
EUR 13,782,656
Cape Verde
HIV
CCM
Delayed approval
2
3
USD 5,321,184
USD 12,578,727
Central African Republic
Malaria
CCM
Immediate approval
2
8
EUR 10,871,833
EUR 30,971,995
Central African Republic
TB
CCM
Not approved
3
n/a
EUR 9,742,228
EUR 22,482,120
Chad
HIV
CCM
Immediate approval
2
8
EUR 29,702,927
EUR 63,244,477
Chad
TB
CCM
Delayed approval
2B
8
EUR 3,427,453
EUR 5,385,007
China
HIV
CCM
Immediate approval
2
6
EUR 15,747,191
EUR 44,128,188
China
Malaria
CCM
Not approved
3
n/a
EUR 29,681,060
EUR 61,332,628
China
TB
CCM
Delayed approval
2B
6
EUR 24,012,517
EUR 87,664,363
Colombia
HIV
CCM
Not approved
3
n/a
EUR 12,254,560
EUR 32,867,073
Colombia
Malaria
CCM
Delayed approval
2
3
EUR 16,997,092
EUR 32,262,166
Colombia
TB
CCM
Not approved
3
n/a
EUR 11,968,726
EUR 22,919,271
Comoros
HIV
CCM
Not approved
4
n/a
EUR 1,235,586
EUR 2,229,001
Comoros
Malaria (disease part)
CCM
Immediate approval
2
5
EUR 5,280,932
EUR 11,788,954
Comoros
Malaria (HSS part)
CCM
Not approved
n/a
n/a
EUR 1,061,171
EUR 2,834,024
Congo (Democratic Republic of)
HIV
CCM
Immediate approval
2
8
USD 79,225,696
USD 262,911,091
Congo (Democratic Republic of)
Malaria
CCM
Immediate approval
2
8
USD 153,997,553
USD 393,102,357
Congo (Democratic Republic of)
TB (disease part + HSS part)
CCM
Not approved
3
n/a
USD 71,422,674
USD 199,682,709
Congo (Republic of)
Malaria
CCM
Delayed approval
2B
6
EUR 25,465,537
EUR 54,135,175
Congo (Republic of)
TB
CCM
Delayed approval
2B
6
EUR 2,303,089
EUR 5,005,041
Cote d'Ivoire
HIV (disease part + HSS part)
CCM
Not approved
3
n/a
EUR 55,758,904
EUR 142,745,182
Cote d'Ivoire
Malaria
CCM
Immediate approval
2
8
EUR 139,365,869
EUR 180,298,316
Cote d'Ivoire
TB
CCM
Not approved
3
n/a
EUR 7,152,767
EUR 17,886,903
Djibouti
Malaria
CCM
Not approved
3
n/a
EUR 4,335,600
EUR 10,391,353
Djibouti
TB
CCM
Not approved
4
n/a
EUR 3,912,029
EUR 8,688,954
Dominican Republic
Malaria
CCM
Delayed approval
2
3
USD 4,492,517
USD 8,703,257
Ecuador
HIV
CCM
Not approved
3
n/a
USD 14,389,246
USD 35,615,171
Ecuador
Malaria
CCM
Delayed approval
2
3
USD 8,374,965
USD 15,108,812
Ecuador
TB
CCM
Not approved
3
n/a
USD 14,066,522
USD 32,819,024
Eritrea
HIV (disease part)
CCM
Immediate approval
2
8
USD 17,071,740
USD 45,135,676
Eritrea
HIV (HSS part)
CCM
Not approved
n/a
n/a
USD 6,087,808
USD 14,939,526
Ethiopia
Malaria (disease part + HSS part)
CCM
Immediate approval
1
n/a
USD 148,412,502
USD 291,064,713
Fiji
TB (disease part + HSS part)
CCM
Delayed approval
2B
3
USD 4,789,119
USD 9,929,474
Gabon
HIV
CCM
Immediate approval
1
n/a
EUR 6,879,029
EUR 17,006,207
Gabon
Malaria
CCM
Not approved
3
n/a
EUR 5,030,319
EUR 13,851,883
Gambia
HIV (disease part + HSS part)
CCM
Immediate approval
2
5
EUR 15,250,763
EUR 36,582,801
Ghana
HIV
CCM
Immediate approval
2
8
USD 51,498,200
USD 99,858,800
Ghana
Malaria (disease part)
CCM
Immediate approval
2
8
USD 39,639,118
USD 158,030,372
Ghana
Malaria (HSS part)
CCM
Not approved
n/a
n/a
USD 4,462,500
USD 13,420,570
Guatemala
HIV (disease part + HSS part)
CCM
Not approved
4
n/a
EUR 37,104,756
EUR 115,595,987
Guatemala
Malaria
CCM
Not approved
3
n/a
EUR 21,586,329
EUR 41,174,990
Guinea-Bissau
TB (HSS part)
CCM
Immediate approval
2
5
EUR 595,684
EUR 1,286,514
Guinea-Bissau
TB (disease part)
CCM
Not approved
n/a
n/a
EUR 7,818,909
EUR 21,213,426
Guyana
HIV (HSS part)
CCM
Immediate approval
2
6
USD 4,637,491
USD 10,094,303
Guyana
HIV (disease part)
CCM
Not approved
n/a
n/a
USD 6,005,402
USD 18,370,517
Guyana
Malaria
CCM
Not approved
3
n/a
USD 2,993,178
USD 5,573,355
Guyana
TB
CCM
Delayed approval
2B
3
USD 3,087,615
USD 7,125,899
Haiti
Malaria
CCM
Delayed approval
2B
5
USD 33,402,457
USD 50,046,179
Haiti
TB (disease part + HSS part)
CCM
Not approved
3
n/a
USD 31,167,222
USD 59,742,348
Honduras
HIV
CCM
Not approved
3
n/a
USD 5,334,334
USD 13,389,159
Honduras
TB (disease part + HSS part)
CCM
Not approved
3
n/a
USD 8,031,166
USD 16,170,525
India
HIV
CCM
Not approved
3
n/a
EUR 21,263,481
EUR 75,212,496
India
Malaria
CCM
Not approved
3
n/a
EUR 39,883,180
EUR 100,310,326
India
TB
CCM
Not approved
3
n/a
EUR 32,420,155
EUR 79,915,954
Indonesia
HIV
CCM
Immediate approval
1
n/a
USD 45,384,545
USD 130,653,560
Indonesia
Malaria
CCM
Delayed approval
2
3
USD 73,453,889
USD 120,092,536
Indonesia
TB
CCM
Immediate approval
1
n/a
USD 28,106,251
USD 93,001,059
Iran
HIV
CCM
Delayed approval
2B
6
USD 10,328,021
USD 32,354,404
Kazakhstan
HIV
CCM
Not approved
3
n/a
USD 13,880,664
USD 35,851,200
Kazakhstan
Malaria
CCM
Not approved
4
n/a
USD 897,612
USD 1,376,877
Kazakhstan
TB
CCM
Delayed approval
2B
3
USD 37,557,518
USD 69,880,919
Kenya
HIV
CCM
Not approved
4
n/a
USD 105,743,946
USD 129,929,146
Kenya
Malaria
CCM
Not approved
3
n/a
USD 89,634,705
USD 200,581,638
Kenya
TB (disease part + HSS part)
CCM
Not approved
3
n/a
USD 41,216,118
USD 137,406,953
Korea (Democratic People's Republic of)
HIV
CCM
Not approved
3
n/a
EUR 15,119,159
EUR 28,699,056
Korea (Democratic People's Republic of)
Malaria
CCM
Immediate approval
2
5
EUR 9,542,511
EUR 18,348,551
Korea (Democratic People's Republic of)
TB
CCM
Delayed approval
2B
5
EUR 17,686,423
EUR 47,102,407
Kyrgyz Republic
HIV
Sub-CCM
Not approved
4
n/a
USD 3,560,042
USD 6,770,643
Kyrgyz Republic
Malaria
CCM
Immediate approval
2
5
USD 4,530,888
USD 8,788,180
Kyrgyz Republic
TB
CCM
Not approved
3
n/a
USD 7,507,988
USD 24,622,765
Lao People's Democratic Republic
HIV (disease part + HSS part)
CCM
Immediate approval
2
8
USD 9,114,326
USD 24,569,609
Lesotho
HIV (disease part + HSS part)
CCM
Immediate approval
2
6
USD 39,773,696
USD 103,429,628
Lesotho
TB
CCM
Delayed approval
2B
6
USD 10,967,381
USD 28,083,618
Liberia
HIV (disease part + HSS part)
CCM
Immediate approval
2
8
USD 20,199,587
USD 78,235,151
Madagascar
HIV
CCM
Immediate approval
2
5
USD 11,768,300
USD 36,037,600
Madagascar
TB
CCM
Delayed approval
2B
5
USD 8,987,239
USD 22,797,620
Mali
HIV (disease part)
CCM
Immediate approval
2
8
EUR 40,526,846
EUR 126,634,447
Mali
HIV (HSS part)
CCM
Not approved
n/a
n/a
EUR 21,852,585
EUR 49,979,708
Mauritania
HIV (HSS part)
CCM
Immediate approval
1
n/a
USD 2,772,376
USD 3,942,505
Mauritania
HIV (disease part)
CCM
Not approved
n/a
n/a
USD 9,367,617
USD 22,266,256
Mauritius
HIV
CCM
Immediate approval
1
n/a
EUR 4,052,662
EUR 7,890,632
Moldova
HIV
CCM
Delayed approval
2B
6
EUR 8,606,392
EUR 16,723,816
Moldova
TB
CCM
Immediate approval
1
n/a
EUR 5,281,042
EUR 13,322,904
Mozambique
HIV (HSS part)
CCM
Immediate approval
2
8
USD 13,177,452
USD 34,874,346
Mozambique
HIV (disease part)
CCM
Not approved
n/a
n/a
USD 39,073,131
USD 170,770,762
Mozambique
Malaria
CCM
Not approved
3
n/a
USD 78,152,630
USD 210,466,897
Namibia
HIV
CCM
Not approved
3
n/a
USD 64,688,284
USD 160,505,034
Nepal
HIV (disease part + HSS part)
CCM
Not approved
3
n/a
USD 35,249,649
USD 90,220,063
Nicaragua
HIV
CCM
Delayed approval
2
3
USD 31,385,337
USD 65,390,510
Nigeria
HIV (HSS part)
CCM
Immediate approval
2
8
USD 75,055,363
USD 178,030,052
Nigeria
HIV (disease part)
CCM
Not approved
n/a
n/a
USD 293,867,577
USD 831,612,641
Nigeria
Malaria
CCM
Delayed approval
2B
8
USD 334,351,033
USD 599,810,494
Nigeria
TB
CCM
Not approved
3
n/a
USD 42,169,586
USD 181,584,855
Pakistan
HIV
CCM
Not approved
3
n/a
USD 18,636,708
USD 66,219,051
Pakistan
TB
CCM
Immediate approval
2
8
USD 9,810,559
USD 26,682,133
Panama
HIV
CCM
Not approved
3
n/a
USD 4,949,840
USD 13,592,440
Papua New Guinea
Malaria
CCM
Immediate approval
2
5
USD 70,139,822
USD 152,252,244
Paraguay
HIV (disease part)
CCM
Immediate approval
2
6
EUR 4,765,763
EUR 13,314,074
Paraguay
HIV (HSS part)
CCM
Not approved
n/a
n/a
EUR 1,514,597
EUR 3,267,216
Paraguay
Malaria
CCM
Not approved
3
n/a
EUR 4,403,483
EUR 8,558,518
Paraguay
TB
CCM
Not approved
3
n/a
EUR 8,277,793
EUR 18,576,825
Peru
HIV (disease part + HSS part)
CCM
Not approved
3
n/a
EUR 30,545,347
EUR 50,546,403
Peru
TB
CCM
Immediate approval
1
n/a
EUR 11,484,622
EUR 22,229,143
Philippines
HIV (disease part + HSS part)
CCM
Not approved
3
n/a
EUR 25,581,667
EUR 42,391,843
Russian Federation
TB
CCM
Not approved
3
n/a
EUR 65,687,022
EUR 139,199,580
Russian Federation
TB (disease part + HSS part)
Sub-CCM
Not approved
4
n/a
EUR 18,808,972
EUR 33,180,557
Rwanda
HIV
CCM
Not approved
3
n/a
USD 15,591,988
USD 38,979,970
Rwanda
Malaria (disease part)
CCM
Immediate approval
2
5
USD 58,567,001
USD 138,469,243
Rwanda
Malaria (HSS part)
CCM
Not approved
n/a
n/a
USD 33,702,875
USD 48,541,601
Sao Tome and Principe
HIV
CCM
Not approved
3
n/a
USD 568,464
USD 1,529,157
Sao Tome and Principe
TB
CCM
Immediate approval
1
n/a
USD 1,132,914
USD 2,608,818
Senegal
HIV (disease part + HSS part)
CCM
Not approved
3
n/a
EUR 54,507,488
EUR 136,440,454
Senegal
TB
CCM
Not approved
3
n/a
EUR 6,930,243
EUR 17,791,333
Serbia
HIV
CCM
Delayed approval
2
3
EUR 3,766,988
EUR 12,406,231
Solomon Islands
HIV (disease part)
CCM
Not approved
n/a
n/a
USD 4,570,062
USD 10,472,323
Solomon Islands
HIV (HSS part)
CCM
Delayed approval
2B
5
USD 845,725
USD 1,686,884
Solomon Islands
TB
CCM
Delayed approval
2B
5
USD 3,608,714
USD 7,334,716
Somalia
HIV (disease part + HSS part)
Non-CCM
Immediate approval
2
5
USD 25,669,049
USD 60,261,684
South Africa
HIV
CCM
Not approved
3
n/a
USD 91,680,358
USD 259,056,796
South Africa
TB
CCM
Not approved
4
n/a
USD 68,229,369
USD 194,670,986
Sri Lanka
Malaria
CCM
Delayed approval
2B
3
USD 24,040,444
USD 40,915,151
Sudan (Northern Sector)
TB (disease part + HSS part)
CCM
Delayed approval
2B
8
USD 17,979,663
USD 58,048,795
Sudan (Southern Sector)
HIV (disease part + HSS part)
Sub-CCM
Not approved
3
n/a
USD 28,482,979
USD 124,015,542
Swaziland
HIV (HSS part)
CCM
Immediate approval
2
6
USD 8,180,726
USD 15,136,442
Swaziland
HIV (disease part)
CCM
Not approved
n/a
n/a
USD 49,055,285
USD 90,214,010
Swaziland
Malaria
CCM
Immediate approval
1
n/a
USD 5,637,713
USD 13,880,938
Swaziland
TB
CCM
Immediate approval
2
6
USD 4,785,540
USD 11,839,346
Tajikistan
HIV
CCM
Immediate approval
2
8
EUR 13,264,761
EUR 34,578,129
Tajikistan
Malaria
CCM
Immediate approval
2
5
EUR 5,224,796
EUR 9,615,246
Tajikistan
TB (disease part + HSS part)
CCM
Immediate approval
2
5
EUR 9,840,404
EUR 17,534,572
Tanzania (United Republic of)
HIV (disease part)
CCM
Immediate approval
2
8
USD 145,848,085
USD 598,106,619
Tanzania (United Republic of)
HIV (HSS part)
CCM
Not approved
n/a
n/a
USD 65,422,207
USD 96,794,019
Tanzania (United Republic of)
Malaria
CCM
Immediate approval
2
5
USD 111,586,404
USD 113,335,025
Thailand
HIV
CCM
Immediate approval
2
6
USD 38,254,259
USD 106,123,200
Thailand
TB
CCM
Immediate approval
1
n/a
USD 12,420,804
USD 30,547,583
Togo
HIV
CCM
Immediate approval
2
8
EUR 31,775,839
EUR 81,340,190
Tunisia
TB
CCM
Delayed approval
2B
3
USD 4,400,014
USD 7,560,548
Turkmenistan
TB
CCM
Not approved
3
n/a
USD 10,649,147
USD 20,279,651
Ukraine
TB
CCM
Not approved
3
n/a
USD 36,251,905
USD 94,715,697
Uruguay
HIV
CCM
Not approved
3
n/a
USD 8,951,242
USD 21,393,157
Uzbekistan
HIV
CCM
Not approved
3
n/a
USD 26,428,887
USD 79,669,868
Uzbekistan
Malaria
CCM
Delayed approval
2B
5
USD 2,789,923
USD 6,144,821
Uzbekistan
TB
CCM
Delayed approval
2B
5
USD 13,881,631
USD 56,124,183
Vietnam
HIV
CCM
Immediate approval
2
8
USD 14,577,204
USD 48,693,061
West Bank and Gaza
TB
Non-CCM
Immediate approval
1
n/a
EUR 972,386
EUR 2,152,074
Yemen
HIV
CCM
Not approved
3
n/a
USD 6,495,225
USD 25,735,775
Yemen
TB
CCM
Not approved
4
n/a
USD 6,767,022
USD 19,880,527
Zambia
HIV (disease part + HSS part)
CCM
Immediate approval
1
n/a
USD 144,079,863
USD 307,273,164
Zanzibar
HIV
CCM
Not approved
4
n/a
EUR 4,127,078
EUR 7,274,018
Zanzibar
Malaria (disease part + HSS part)
CCM
Immediate approval
2
5
EUR 5,648,340
EUR 12,355,905
Zimbabwe
HIV
CCM
Immediate approval
2
8
USD 86,821,730
USD 296,752,070
Zimbabwe
Malaria (disease part + HSS part)
CCM
Immediate approval
2
5
USD 70,994,472
USD 141,316,927
Zimbabwe
TB
CCM
Delayed approval
2B
8
USD 29,538,652
USD 58,298,297
Table 6: Round 8 results for regional applicants
Country
Disease
Applicant
Decision
Category
(defined above)
Composite Index
(defined above)
Requested
(Years 1-2)
Requested
(Years 1-5)
CARE (India, Nepal, Bangladesh)
HIV
Regional organization
Not approved
4
n/a
EUR 14,145,331
EUR 40,817,080
CCLAB (Guatemala, El Salvador, Honduras, Nicaragua, Dom. Rep., Panama, Costa Rica, Belize)
HIV
Regional Coordinating Mechanism
Not approved
4
n/a
USD 20,292,270
USD 46,811,258
COPRECOS LAC (Colombia, El Salvador, Nicaragua, Panama, Paraguay, Dom. Rep., Uruguay, Argentina, Belize, Brazil, Ecuador, Guatemala, Haiti, Honduras, Peru, Chile, Costa Rica, Venezuela)
HIV
Regional organization
Not approved
3
n/a
USD 23,122,297
USD 68,666,796
GLIA (Burundi, DRC, Kenya, Rwanda, Tanzania, Uganda)
HIV
Regional organization
Not approved
4
n/a
USD 10,824,037
USD 27,044,765
SADC (Angola, Botswana, Namibia, Zambia, Zimbabwe)
Malaria (disease part + HSS part)
Regional Coordinating Mechanism
Not approved
3
n/a
USD 36,018,686
USD 86,985,372
- Category 1: Approved proposals requiring no or minor clarifications, which need to be provided within 8 weeks and then given a final approval by the TRP Chair and/or Vice-Chair.
- Category 2: Proposals that are approved in principle, subject to the required clarifications being provided within a limited timeframe (6 weeks for the applicant to provide an initial detailed response to the TRP queries, and a further 3 months to obtain the final TRP approval should further clarifications be requested). The TRP Chair and Vice-Chair need to give final approval.
- Category 2B: Proposals that are treated as those in Category 2, but are regarded as being relatively weak, on grounds of technical merit and/or issues of feasibility and likelihood of effective implementation.
- Category 3: Proposals not approved in their present form, though applicants are encouraged to resubmit in Round 9 following major revision.
- Category 4: Proposals that are rejected, with applicants not encouraged to resubmit in any similar form.
The Board approved "in principle" (to use its precise words) all proposals in Categories 1, 2 and 2B. However, some of the approvals are immediate and some are delayed, depending on future availability of funds. The prioritization is handled as follows:
- Category 1 proposals are approved immediately.
- Each country submitting a Category 2 or 2B proposal is assigned a disease burden index of 4 or 1 according to whether the disease burden is "very high" or not "very high". And each such country is assigned a poverty index of 4, 2 or 0 according to whether the country is low income, lower-middle income, or upper-middle income. The sum of these two indexes creates the Composite Index, whose value is therefore between 8 and 1. The higher the country's Composite Index, the sooner its Category 2 or 2B proposal will be approved.
- Category 2 proposals with a Composite Index of 8, 6 or 5 are immediately approved.
- Remaining Category 2 and 2B proposals will be approved in the following order, as pledges by donors to the Fund become available in the course of 2008-9:
The number of Round 8 grants per Category and Composite Index are as follows:
Table 4: Round 8 results by Category and Composite Index
|
Category and Composite Index |
Number of proposals |
Amount requested (Years 1-2) |
| Immediate approval: Category 1 |
16 |
USD 0.45 b. |
| Immediate approval: Category 2, Composite Index 8, 6 or 5 |
43 |
USD 1.68 b. |
| Delayed approval: Category 2, Composite Index 3 |
8 |
USD 0.18 b. |
| Delayed approval: Category 2B, Composite Index 8 |
6 |
USD 0.44 b. |
| Delayed approval: Category 2B, Composite Index 6 |
6 |
USD 0.10 b. |
| Delayed approval: Category 2B, Composite Index 5 |
8 |
USD 0.13 b. |
| Delayed approval: Category 2B, Composite Index 3 |
7 |
USD 0.09 b. |
| Subtotal: All Approved Proposals: |
94 |
USD 3.06 b. |
| Not Approved: Category 3 |
63 |
USD 1.75 b. |
| Not Approved: Category 4 |
17 |
USD 0.43 b. |
| Not Approved: Removed sub-components of approved proposals |
n/a |
USD 0.56 b. |
| Subtotal: All Non-Approved Proposals: |
80 |
USD 2.73 b. |
| Total: All Proposals |
174 |
USD 5.79 b. |
Round 8 results by applicant were as in Tables 5 and 6, below.
Table 5: Round 8 Results, by Country
|
Country |
Disease component |
Applicant |
Decision |
Category (defined above) |
Composite Index (defined above) |
Amount requested (Years 1-2) |
Amount requested (Years 1-5) |
| Afghanistan | Malaria (disease part + HSS part) |
CCM |
Delayed approval |
2B |
5 |
EUR 30,075,545 |
EUR 55,397,259 |
| Afghanistan | TB |
CCM |
Immediate approval |
1 |
n/a |
EUR 7,394,272 |
EUR 22,669,094 |
| Algeria | HIV |
CCM |
Not approved |
4 |
n/a |
USD 15,252,168 |
USD 32,720,961 |
| Angola | HIV |
CCM |
Not approved |
4 |
n/a |
USD 75,142,046 |
USD 235,955,998 |
| Angola | TB |
CCM |
Not approved |
4 |
n/a |
USD 11,756,766 |
USD 25,098,444 |
| Armenia | HIV (HSS part) |
CCM |
Immediate approval |
2 |
6 |
EUR 1,466,930 |
EUR 2,062,995 |
| Armenia | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
EUR 2,394,212 |
EUR 6,257,962 |
| Armenia | TB |
CCM |
Immediate approval |
1 |
n/a |
EUR 2,006,371 |
EUR 6,205,708 |
| Bangladesh | HIV |
CCM |
Not approved |
3 |
n/a |
USD 14,964,866 |
USD 48,892,309 |
| Bangladesh | Malaria |
CCM |
Not approved |
3 |
n/a |
USD 22,729,707 |
USD 68,436,372 |
| Bangladesh | TB (disease part + HSS part) |
CCM |
Immediate approval |
2 |
8 |
USD 5,627,763 |
USD 77,430,875 |
| Belarus | HIV (disease part + HSS part) |
CCM |
Immediate approval |
1 |
n/a |
EUR 11,120,812 |
EUR 25,389,385 |
| Belarus | TB |
CCM |
Not approved |
3 |
n/a |
EUR 14,254,281 |
EUR 31,226,265 |
| Benin | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 26,909,499 |
EUR 26,909,499 |
| Benin | TB |
CCM |
Not approved |
3 |
n/a |
EUR 3,556,947 |
EUR 6,658,804 |
| Bolivia | HIV |
CCM |
Not approved |
3 |
n/a |
USD 7,763,930 |
USD 23,802,395 |
| Bolivia | Malaria |
CCM |
Delayed approval |
2B |
3 |
USD 6,744,407 |
USD 15,578,630 |
| Bolivia | TB |
CCM |
Not approved |
4 |
n/a |
USD 9,191,385 |
USD 16,777,841 |
| Bosnia & Herzegovina | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 12,336,077 |
EUR 29,441,571 |
| Bosnia & Herzegovina | TB |
CCM |
Not approved |
3 |
n/a |
EUR 5,722,028 |
EUR 9,796,973 |
| Brazil | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 9,372,000 |
EUR 30,000,000 |
| Brazil | Malaria |
CCM |
Delayed approval |
2 |
3 |
EUR 20,659,117 |
EUR 42,023,909 |
| Brazil | TB |
CCM |
Not approved |
3 |
n/a |
EUR 40,191,174 |
EUR 80,560,970 |
| Bulgaria | TB |
CCM |
Delayed approval |
2B |
3 |
EUR 3,661,435 |
EUR 10,527,766 |
| Burkina Faso | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 24,844,539 |
EUR 48,473,676 |
| Burkina Faso | Malaria |
CCM |
Immediate approval |
2 |
8 |
EUR 53,120,303 |
EUR 63,203,438 |
| Burkina Faso | TB (disease part + HSS part) |
CCM |
Delayed approval |
2B |
8 |
EUR 12,045,997 |
EUR 27,167,685 |
| Burundi | HIV |
CCM |
Delayed approval |
2B |
8 |
USD 41,315,145 |
USD 159,105,087 |
| Cambodia | HIV |
CCM |
Not approved |
3 |
n/a |
USD 38,283,888 |
USD 134,514,948 |
| Cambodia | TB (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
USD 11,449,113 |
USD 34,686,505 |
| Cameroon | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 28,961,003 |
EUR 66,797,527 |
| Cameroon | TB |
CCM |
Not approved |
3 |
n/a |
EUR 7,015,400 |
EUR 13,782,656 |
| Cape Verde | HIV |
CCM |
Delayed approval |
2 |
3 |
USD 5,321,184 |
USD 12,578,727 |
| Central African Republic | Malaria |
CCM |
Immediate approval |
2 |
8 |
EUR 10,871,833 |
EUR 30,971,995 |
| Central African Republic | TB |
CCM |
Not approved |
3 |
n/a |
EUR 9,742,228 |
EUR 22,482,120 |
| Chad | HIV |
CCM |
Immediate approval |
2 |
8 |
EUR 29,702,927 |
EUR 63,244,477 |
| Chad | TB |
CCM |
Delayed approval |
2B |
8 |
EUR 3,427,453 |
EUR 5,385,007 |
| China | HIV |
CCM |
Immediate approval |
2 |
6 |
EUR 15,747,191 |
EUR 44,128,188 |
| China | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 29,681,060 |
EUR 61,332,628 |
| China | TB |
CCM |
Delayed approval |
2B |
6 |
EUR 24,012,517 |
EUR 87,664,363 |
| Colombia | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 12,254,560 |
EUR 32,867,073 |
| Colombia | Malaria |
CCM |
Delayed approval |
2 |
3 |
EUR 16,997,092 |
EUR 32,262,166 |
| Colombia | TB |
CCM |
Not approved |
3 |
n/a |
EUR 11,968,726 |
EUR 22,919,271 |
| Comoros | HIV |
CCM |
Not approved |
4 |
n/a |
EUR 1,235,586 |
EUR 2,229,001 |
| Comoros | Malaria (disease part) |
CCM |
Immediate approval |
2 |
5 |
EUR 5,280,932 |
EUR 11,788,954 |
| Comoros | Malaria (HSS part) |
CCM |
Not approved |
n/a |
n/a |
EUR 1,061,171 |
EUR 2,834,024 |
| Congo (Democratic Republic of) | HIV |
CCM |
Immediate approval |
2 |
8 |
USD 79,225,696 |
USD 262,911,091 |
| Congo (Democratic Republic of) | Malaria |
CCM |
Immediate approval |
2 |
8 |
USD 153,997,553 |
USD 393,102,357 |
| Congo (Democratic Republic of) | TB (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
USD 71,422,674 |
USD 199,682,709 |
| Congo (Republic of) | Malaria |
CCM |
Delayed approval |
2B |
6 |
EUR 25,465,537 |
EUR 54,135,175 |
| Congo (Republic of) | TB |
CCM |
Delayed approval |
2B |
6 |
EUR 2,303,089 |
EUR 5,005,041 |
| Cote d'Ivoire | HIV (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
EUR 55,758,904 |
EUR 142,745,182 |
| Cote d'Ivoire | Malaria |
CCM |
Immediate approval |
2 |
8 |
EUR 139,365,869 |
EUR 180,298,316 |
| Cote d'Ivoire | TB |
CCM |
Not approved |
3 |
n/a |
EUR 7,152,767 |
EUR 17,886,903 |
| Djibouti | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 4,335,600 |
EUR 10,391,353 |
| Djibouti | TB |
CCM |
Not approved |
4 |
n/a |
EUR 3,912,029 |
EUR 8,688,954 |
| Dominican Republic | Malaria |
CCM |
Delayed approval |
2 |
3 |
USD 4,492,517 |
USD 8,703,257 |
| Ecuador | HIV |
CCM |
Not approved |
3 |
n/a |
USD 14,389,246 |
USD 35,615,171 |
| Ecuador | Malaria |
CCM |
Delayed approval |
2 |
3 |
USD 8,374,965 |
USD 15,108,812 |
| Ecuador | TB |
CCM |
Not approved |
3 |
n/a |
USD 14,066,522 |
USD 32,819,024 |
| Eritrea | HIV (disease part) |
CCM |
Immediate approval |
2 |
8 |
USD 17,071,740 |
USD 45,135,676 |
| Eritrea | HIV (HSS part) |
CCM |
Not approved |
n/a |
n/a |
USD 6,087,808 |
USD 14,939,526 |
| Ethiopia | Malaria (disease part + HSS part) |
CCM |
Immediate approval |
1 |
n/a |
USD 148,412,502 |
USD 291,064,713 |
| Fiji | TB (disease part + HSS part) |
CCM |
Delayed approval |
2B |
3 |
USD 4,789,119 |
USD 9,929,474 |
| Gabon | HIV |
CCM |
Immediate approval |
1 |
n/a |
EUR 6,879,029 |
EUR 17,006,207 |
| Gabon | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 5,030,319 |
EUR 13,851,883 |
| Gambia | HIV (disease part + HSS part) |
CCM |
Immediate approval |
2 |
5 |
EUR 15,250,763 |
EUR 36,582,801 |
| Ghana | HIV |
CCM |
Immediate approval |
2 |
8 |
USD 51,498,200 |
USD 99,858,800 |
| Ghana | Malaria (disease part) |
CCM |
Immediate approval |
2 |
8 |
USD 39,639,118 |
USD 158,030,372 |
| Ghana | Malaria (HSS part) |
CCM |
Not approved |
n/a |
n/a |
USD 4,462,500 |
USD 13,420,570 |
| Guatemala | HIV (disease part + HSS part) |
CCM |
Not approved |
4 |
n/a |
EUR 37,104,756 |
EUR 115,595,987 |
| Guatemala | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 21,586,329 |
EUR 41,174,990 |
| Guinea-Bissau | TB (HSS part) |
CCM |
Immediate approval |
2 |
5 |
EUR 595,684 |
EUR 1,286,514 |
| Guinea-Bissau | TB (disease part) |
CCM |
Not approved |
n/a |
n/a |
EUR 7,818,909 |
EUR 21,213,426 |
| Guyana | HIV (HSS part) |
CCM |
Immediate approval |
2 |
6 |
USD 4,637,491 |
USD 10,094,303 |
| Guyana | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
USD 6,005,402 |
USD 18,370,517 |
| Guyana | Malaria |
CCM |
Not approved |
3 |
n/a |
USD 2,993,178 |
USD 5,573,355 |
| Guyana | TB |
CCM |
Delayed approval |
2B |
3 |
USD 3,087,615 |
USD 7,125,899 |
| Haiti | Malaria |
CCM |
Delayed approval |
2B |
5 |
USD 33,402,457 |
USD 50,046,179 |
| Haiti | TB (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
USD 31,167,222 |
USD 59,742,348 |
| Honduras | HIV |
CCM |
Not approved |
3 |
n/a |
USD 5,334,334 |
USD 13,389,159 |
| Honduras | TB (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
USD 8,031,166 |
USD 16,170,525 |
| India | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 21,263,481 |
EUR 75,212,496 |
| India | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 39,883,180 |
EUR 100,310,326 |
| India | TB |
CCM |
Not approved |
3 |
n/a |
EUR 32,420,155 |
EUR 79,915,954 |
| Indonesia | HIV |
CCM |
Immediate approval |
1 |
n/a |
USD 45,384,545 |
USD 130,653,560 |
| Indonesia | Malaria |
CCM |
Delayed approval |
2 |
3 |
USD 73,453,889 |
USD 120,092,536 |
| Indonesia | TB |
CCM |
Immediate approval |
1 |
n/a |
USD 28,106,251 |
USD 93,001,059 |
| Iran | HIV |
CCM |
Delayed approval |
2B |
6 |
USD 10,328,021 |
USD 32,354,404 |
| Kazakhstan | HIV |
CCM |
Not approved |
3 |
n/a |
USD 13,880,664 |
USD 35,851,200 |
| Kazakhstan | Malaria |
CCM |
Not approved |
4 |
n/a |
USD 897,612 |
USD 1,376,877 |
| Kazakhstan | TB |
CCM |
Delayed approval |
2B |
3 |
USD 37,557,518 |
USD 69,880,919 |
| Kenya | HIV |
CCM |
Not approved |
4 |
n/a |
USD 105,743,946 |
USD 129,929,146 |
| Kenya | Malaria |
CCM |
Not approved |
3 |
n/a |
USD 89,634,705 |
USD 200,581,638 |
| Kenya | TB (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
USD 41,216,118 |
USD 137,406,953 |
| Korea (Democratic People's Republic of) | HIV |
CCM |
Not approved |
3 |
n/a |
EUR 15,119,159 |
EUR 28,699,056 |
| Korea (Democratic People's Republic of) | Malaria |
CCM |
Immediate approval |
2 |
5 |
EUR 9,542,511 |
EUR 18,348,551 |
| Korea (Democratic People's Republic of) | TB |
CCM |
Delayed approval |
2B |
5 |
EUR 17,686,423 |
EUR 47,102,407 |
| Kyrgyz Republic | HIV |
Sub-CCM |
Not approved |
4 |
n/a |
USD 3,560,042 |
USD 6,770,643 |
| Kyrgyz Republic | Malaria |
CCM |
Immediate approval |
2 |
5 |
USD 4,530,888 |
USD 8,788,180 |
| Kyrgyz Republic | TB |
CCM |
Not approved |
3 |
n/a |
USD 7,507,988 |
USD 24,622,765 |
| Lao People's Democratic Republic | HIV (disease part + HSS part) |
CCM |
Immediate approval |
2 |
8 |
USD 9,114,326 |
USD 24,569,609 |
| Lesotho | HIV (disease part + HSS part) |
CCM |
Immediate approval |
2 |
6 |
USD 39,773,696 |
USD 103,429,628 |
| Lesotho | TB |
CCM |
Delayed approval |
2B |
6 |
USD 10,967,381 |
USD 28,083,618 |
| Liberia | HIV (disease part + HSS part) |
CCM |
Immediate approval |
2 |
8 |
USD 20,199,587 |
USD 78,235,151 |
| Madagascar | HIV |
CCM |
Immediate approval |
2 |
5 |
USD 11,768,300 |
USD 36,037,600 |
| Madagascar | TB |
CCM |
Delayed approval |
2B |
5 |
USD 8,987,239 |
USD 22,797,620 |
| Mali | HIV (disease part) |
CCM |
Immediate approval |
2 |
8 |
EUR 40,526,846 |
EUR 126,634,447 |
| Mali | HIV (HSS part) |
CCM |
Not approved |
n/a |
n/a |
EUR 21,852,585 |
EUR 49,979,708 |
| Mauritania | HIV (HSS part) |
CCM |
Immediate approval |
1 |
n/a |
USD 2,772,376 |
USD 3,942,505 |
| Mauritania | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
USD 9,367,617 |
USD 22,266,256 |
| Mauritius | HIV |
CCM |
Immediate approval |
1 |
n/a |
EUR 4,052,662 |
EUR 7,890,632 |
| Moldova | HIV |
CCM |
Delayed approval |
2B |
6 |
EUR 8,606,392 |
EUR 16,723,816 |
| Moldova | TB |
CCM |
Immediate approval |
1 |
n/a |
EUR 5,281,042 |
EUR 13,322,904 |
| Mozambique | HIV (HSS part) |
CCM |
Immediate approval |
2 |
8 |
USD 13,177,452 |
USD 34,874,346 |
| Mozambique | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
USD 39,073,131 |
USD 170,770,762 |
| Mozambique | Malaria |
CCM |
Not approved |
3 |
n/a |
USD 78,152,630 |
USD 210,466,897 |
| Namibia | HIV |
CCM |
Not approved |
3 |
n/a |
USD 64,688,284 |
USD 160,505,034 |
| Nepal | HIV (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
USD 35,249,649 |
USD 90,220,063 |
| Nicaragua | HIV |
CCM |
Delayed approval |
2 |
3 |
USD 31,385,337 |
USD 65,390,510 |
| Nigeria | HIV (HSS part) |
CCM |
Immediate approval |
2 |
8 |
USD 75,055,363 |
USD 178,030,052 |
| Nigeria | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
USD 293,867,577 |
USD 831,612,641 |
| Nigeria | Malaria |
CCM |
Delayed approval |
2B |
8 |
USD 334,351,033 |
USD 599,810,494 |
| Nigeria | TB |
CCM |
Not approved |
3 |
n/a |
USD 42,169,586 |
USD 181,584,855 |
| Pakistan | HIV |
CCM |
Not approved |
3 |
n/a |
USD 18,636,708 |
USD 66,219,051 |
| Pakistan | TB |
CCM |
Immediate approval |
2 |
8 |
USD 9,810,559 |
USD 26,682,133 |
| Panama | HIV |
CCM |
Not approved |
3 |
n/a |
USD 4,949,840 |
USD 13,592,440 |
| Papua New Guinea | Malaria |
CCM |
Immediate approval |
2 |
5 |
USD 70,139,822 |
USD 152,252,244 |
| Paraguay | HIV (disease part) |
CCM |
Immediate approval |
2 |
6 |
EUR 4,765,763 |
EUR 13,314,074 |
| Paraguay | HIV (HSS part) |
CCM |
Not approved |
n/a |
n/a |
EUR 1,514,597 |
EUR 3,267,216 |
| Paraguay | Malaria |
CCM |
Not approved |
3 |
n/a |
EUR 4,403,483 |
EUR 8,558,518 |
| Paraguay | TB |
CCM |
Not approved |
3 |
n/a |
EUR 8,277,793 |
EUR 18,576,825 |
| Peru | HIV (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
EUR 30,545,347 |
EUR 50,546,403 |
| Peru | TB |
CCM |
Immediate approval |
1 |
n/a |
EUR 11,484,622 |
EUR 22,229,143 |
| Philippines | HIV (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
EUR 25,581,667 |
EUR 42,391,843 |
| Russian Federation | TB |
CCM |
Not approved |
3 |
n/a |
EUR 65,687,022 |
EUR 139,199,580 |
| Russian Federation | TB (disease part + HSS part) |
Sub-CCM |
Not approved |
4 |
n/a |
EUR 18,808,972 |
EUR 33,180,557 |
| Rwanda | HIV |
CCM |
Not approved |
3 |
n/a |
USD 15,591,988 |
USD 38,979,970 |
| Rwanda | Malaria (disease part) |
CCM |
Immediate approval |
2 |
5 |
USD 58,567,001 |
USD 138,469,243 |
| Rwanda | Malaria (HSS part) |
CCM |
Not approved |
n/a |
n/a |
USD 33,702,875 |
USD 48,541,601 |
| Sao Tome and Principe | HIV |
CCM |
Not approved |
3 |
n/a |
USD 568,464 |
USD 1,529,157 |
| Sao Tome and Principe | TB |
CCM |
Immediate approval |
1 |
n/a |
USD 1,132,914 |
USD 2,608,818 |
| Senegal | HIV (disease part + HSS part) |
CCM |
Not approved |
3 |
n/a |
EUR 54,507,488 |
EUR 136,440,454 |
| Senegal | TB |
CCM |
Not approved |
3 |
n/a |
EUR 6,930,243 |
EUR 17,791,333 |
| Serbia | HIV |
CCM |
Delayed approval |
2 |
3 |
EUR 3,766,988 |
EUR 12,406,231 |
| Solomon Islands | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
USD 4,570,062 |
USD 10,472,323 |
| Solomon Islands | HIV (HSS part) |
CCM |
Delayed approval |
2B |
5 |
USD 845,725 |
USD 1,686,884 |
| Solomon Islands | TB |
CCM |
Delayed approval |
2B |
5 |
USD 3,608,714 |
USD 7,334,716 |
| Somalia | HIV (disease part + HSS part) |
Non-CCM |
Immediate approval |
2 |
5 |
USD 25,669,049 |
USD 60,261,684 |
| South Africa | HIV |
CCM |
Not approved |
3 |
n/a |
USD 91,680,358 |
USD 259,056,796 |
| South Africa | TB |
CCM |
Not approved |
4 |
n/a |
USD 68,229,369 |
USD 194,670,986 |
| Sri Lanka | Malaria |
CCM |
Delayed approval |
2B |
3 |
USD 24,040,444 |
USD 40,915,151 |
| Sudan (Northern Sector) | TB (disease part + HSS part) |
CCM |
Delayed approval |
2B |
8 |
USD 17,979,663 |
USD 58,048,795 |
| Sudan (Southern Sector) | HIV (disease part + HSS part) |
Sub-CCM |
Not approved |
3 |
n/a |
USD 28,482,979 |
USD 124,015,542 |
| Swaziland | HIV (HSS part) |
CCM |
Immediate approval |
2 |
6 |
USD 8,180,726 |
USD 15,136,442 |
| Swaziland | HIV (disease part) |
CCM |
Not approved |
n/a |
n/a |
USD 49,055,285 |
USD 90,214,010 |
| Swaziland | Malaria |
CCM |
Immediate approval |
1 |
n/a |
USD 5,637,713 |
USD 13,880,938 |
| Swaziland | TB |
CCM |
Immediate approval |
2 |
6 |
USD 4,785,540 |
USD 11,839,346 |
| Tajikistan | HIV |
CCM |
Immediate approval |
2 |
8 |
EUR 13,264,761 |
EUR 34,578,129 |
| Tajikistan | Malaria |
CCM |
Immediate approval |
2 |
5 |
EUR 5,224,796 |
EUR 9,615,246 |
| Tajikistan | TB (disease part + HSS part) |
CCM |
Immediate approval |
2 |
5 |
EUR 9,840,404 |
EUR 17,534,572 |
| Tanzania (United Republic of) | HIV (disease part) |
CCM |
Immediate approval |
2 |
8 |
USD 145,848,085 |
USD 598,106,619 |
| Tanzania (United Republic of) | HIV (HSS part) |
CCM |
Not approved |
n/a |
n/a |
USD 65,422,207 |
USD 96,794,019 |
| Tanzania (United Republic of) | Malaria |
CCM |
Immediate approval |
2 |
5 |
USD 111,586,404 |
USD 113,335,025 |
| Thailand | HIV |
CCM |
Immediate approval |
2 |
6 |
USD 38,254,259 |
USD 106,123,200 |
| Thailand | TB |
CCM |
Immediate approval |
1 |
n/a |
USD 12,420,804 |
USD 30,547,583 |
| Togo | HIV |
CCM |
Immediate approval |
2 |
8 |
EUR 31,775,839 |
EUR 81,340,190 |
| Tunisia | TB |
CCM |
Delayed approval |
2B |
3 |
USD 4,400,014 |
USD 7,560,548 |
| Turkmenistan | TB |
CCM |
Not approved |
3 |
n/a |
USD 10,649,147 |
USD 20,279,651 |
| Ukraine | TB |
CCM |
Not approved |
3 |
n/a |
USD 36,251,905 |
USD 94,715,697 |
| Uruguay | HIV |
CCM |
Not approved |
3 |
n/a |
USD 8,951,242 |
USD 21,393,157 |
| Uzbekistan | HIV |
CCM |
Not approved |
3 |
n/a |
USD 26,428,887 |
USD 79,669,868 |
| Uzbekistan | Malaria |
CCM |
Delayed approval |
2B |
5 |
USD 2,789,923 |
USD 6,144,821 |
| Uzbekistan | TB |
CCM |
Delayed approval |
2B |
5 |
USD 13,881,631 |
USD 56,124,183 |
| Vietnam | HIV |
CCM |
Immediate approval |
2 |
8 |
USD 14,577,204 |
USD 48,693,061 |
| West Bank and Gaza | TB |
Non-CCM |
Immediate approval |
1 |
n/a |
EUR 972,386 |
EUR 2,152,074 |
| Yemen | HIV |
CCM |
Not approved |
3 |
n/a |
USD 6,495,225 |
USD 25,735,775 |
| Yemen | TB |
CCM |
Not approved |
4 |
n/a |
USD 6,767,022 |
USD 19,880,527 |
| Zambia | HIV (disease part + HSS part) |
CCM |
Immediate approval |
1 |
n/a |
USD 144,079,863 |
USD 307,273,164 |
| Zanzibar | HIV |
CCM |
Not approved |
4 |
n/a |
EUR 4,127,078 |
EUR 7,274,018 |
| Zanzibar | Malaria (disease part + HSS part) |
CCM |
Immediate approval |
2 |
5 |
EUR 5,648,340 |
EUR 12,355,905 |
| Zimbabwe | HIV |
CCM |
Immediate approval |
2 |
8 |
USD 86,821,730 |
USD 296,752,070 |
| Zimbabwe | Malaria (disease part + HSS part) |
CCM |
Immediate approval |
2 |
5 |
USD 70,994,472 |
USD 141,316,927 |
| Zimbabwe | TB |
CCM |
Delayed approval |
2B |
8 |
USD 29,538,652 |
USD 58,298,297 |
Table 6: Round 8 results for regional applicants
|
Country |
Disease |
Applicant |
Decision |
Category (defined above) |
Composite Index (defined above) |
Requested (Years 1-2) |
Requested (Years 1-5) |
| CARE (India, Nepal, Bangladesh) | HIV |
Regional organization |
Not approved |
4 |
n/a |
EUR 14,145,331 |
EUR 40,817,080 |
| CCLAB (Guatemala, El Salvador, Honduras, Nicaragua, Dom. Rep., Panama, Costa Rica, Belize) | HIV |
Regional Coordinating Mechanism |
Not approved |
4 |
n/a |
USD 20,292,270 |
USD 46,811,258 |
| COPRECOS LAC (Colombia, El Salvador, Nicaragua, Panama, Paraguay, Dom. Rep., Uruguay, Argentina, Belize, Brazil, Ecuador, Guatemala, Haiti, Honduras, Peru, Chile, Costa Rica, Venezuela) | HIV |
Regional organization |
Not approved |
3 |
n/a |
USD 23,122,297 |
USD 68,666,796 |
| GLIA (Burundi, DRC, Kenya, Rwanda, Tanzania, Uganda) | HIV |
Regional organization |
Not approved |
4 |
n/a |
USD 10,824,037 |
USD 27,044,765 |
| SADC (Angola, Botswana, Namibia, Zambia, Zimbabwe) | Malaria (disease part + HSS part) |
Regional Coordinating Mechanism |
Not approved |
3 |
n/a |
USD 36,018,686 |
USD 86,985,372 |
